| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.37 | 0.02 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.36 | 0.01 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.33 | 0.01 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.3 | 0.09 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.27 | 0.09 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.23 | 0.07 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.008 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.19 | 0.2 |